Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review article synthesizing current knowledge and future directions in CRISPR-based gene therapy for hemophilia, without reporting original empirical findings or clinical trial results.
A structured literature review synthesizing current evidence on CRISPR-Cas9 therapeutic applications, identifying clinical advances, translational hurdles, and emerging alternatives without reporting original trial data or effect sizes.
Retrospective single-centre assessment of theoretical eligibility and drug-drug interactions; descriptive analysis without a comparator, control group, or clinical outcome measurement.
A conceptual and critical synthesis of an emerging biological strategy without original experimental data, clinical trials, or validated clinical outcomes in the source population.
A single-case report from an ongoing Phase Ib trial describing one patient's response; while the outcome is noteworthy, case reports lack comparison groups and generalizability to support clinical practice change.
This is a narrative review examining molecular mechanisms of replication stress tolerance in ATL; it synthesizes existing knowledge and proposes mechanistic hypotheses rather than presenting original experimental results or clinical trial data.
A comprehensive review synthesizing the state of mRNA cancer therapeutics across design, delivery, and clinical translation—expert framing rather than a new empirical finding.
A narrative review of preclinical literature synthesizing nanocarrier design and CRISPR delivery mechanisms, raising research directions rather than reporting original empirical evidence or clinical outcomes.